Publications

Position statement regarding newborn screening for muscular dystrophy

February, 2015

This statement outlines the National Screening Unit's position on screening for muscular dystrophy.

View publication:

Position statement regarding newborn screening for muscular dystrophy (pdf, 820 KB)

Bethesda 2001 (NZ Modified) codes for Cytology Laboratories

August, 2014

Updated August 2014. This document replaces v5, October 2013.

View publication:

Bethesda 2001 (NZ Modified) codes for Cytology Laboratories (pdf, 296 KB)

Cost-effectiveness of Newborn Screening for Severe Combined Immune Deficiency

March, 2014

A report on testing for severe combined immune deficiency (SCID) in New Zealand as part of the Newborn Metabolic Screening Programme. It was prepared for the National Screening Unit by Health Partners Consulting Group Ltd.

View publication:

Cost-effectiveness of Newborn Screening for Severe Combined Immune Deficiency (pdf, 696 KB)

NCSP Monitoring and Evaluation: Cervical Cancer Case Reviews

February, 2014

Background and external link to the New Zealand Medical Journal article "Monitoring the performance of New Zealand's National Cervical Screening Programme through data linkage" by Dr Hazel Lewis.

View publication:

NCSP Monitoring and Evaluation: Cervical Cancer Case Reviews (pdf, 130 KB)

Screening for Severe Combined Immune Deficiency – Literature Review

December, 2013

This literature review was intended to inform an economic analysis of the cost-effectiveness of including testing for Severe Combined Immune Deficiency (SCID) in the Newborn Metabolic Screening Programme. It was prepared for the National Screening Unit by Health Partners Consulting Group Ltd.

View publication:

SNOMED Coding for Histology

January, 2013

Updated January 2013. National Cervical Screening Programme, Ministry of Health.

View publication:

SNOMED Coding for Histology (pdf, 183 KB)

Interval cancers in BreastScreen Aotearoa 1999-2007

June, 2012

The purpose of this report is to present information on 2 year interval breast cancers from the BreastScreen Aotearoa (BSA) mammographic screening programme and to compare this with published results from other services.